These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3843895)
21. [Clinical value of morphine via the oral route in the treatment of pain in cancer patients in the terminal stage]. Hilaire J; Kammerer J Rev Infirm; 1984 Sep; 34(15):58-60. PubMed ID: 6567975 [No Abstract] [Full Text] [Related]
22. [Nurses role in treating pain of cancer patients]. Li S Zhonghua Hu Li Za Zhi; 1993 Aug; 28(8):463-6. PubMed ID: 8111907 [No Abstract] [Full Text] [Related]
23. Medical applications of heroin. Mount BM Can Med Assoc J; 1979 Feb; 120(4):405-7. PubMed ID: 445280 [No Abstract] [Full Text] [Related]
24. The tragedy of needless pain. Haq MM Natl Med J India; 1993; 6(2):98. PubMed ID: 8477227 [No Abstract] [Full Text] [Related]
25. Morphine and diamorphine in the terminally ill patient. Twycross RG Acta Anaesthesiol Scand Suppl; 1982; 74():128-34. PubMed ID: 6953726 [TBL] [Abstract][Full Text] [Related]
26. The argument against therapeutic use of heroin in pain management. Lipman AG Am J Hosp Pharm; 1993 May; 50(5):996-8. PubMed ID: 8506879 [No Abstract] [Full Text] [Related]
27. [Oral narcotics: the Brompton mixture. Our experience in its use in cancer patients]. Aliaga Font L; Libkind A; Litvan H; Rojas E; Barbosa D; Campos J; Mayoral J; Castro I Rev Esp Anestesiol Reanim; 1983; 30(6):230-6. PubMed ID: 6658109 [No Abstract] [Full Text] [Related]
28. [The importance of pain control with morphine for terminally ill patient care for at home]. Ashino Y; Muto J; Ooigawa K; Kanno A; Inoue H; Kudo S Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():477-80; discussion 481. PubMed ID: 7528490 [TBL] [Abstract][Full Text] [Related]
29. Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain and chronic pain due to cancer. Kaiko RF; Wallenstein SL; Rogers A; Grabinski P; Houde RW NIDA Res Monogr; 1981 Feb; 34():213-9. PubMed ID: 6783935 [TBL] [Abstract][Full Text] [Related]
30. Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report. Bruera E; Macmillan K; Selmser P; MacDonald NR Pain; 1990 Oct; 43(1):91-94. PubMed ID: 1703651 [TBL] [Abstract][Full Text] [Related]
31. Use of morphine: lifting the mantle of mystery. Copperman H Nurs Mirror; 1979 Jul; 149(1):40-1. PubMed ID: 256131 [No Abstract] [Full Text] [Related]
33. [Pain and opioids: reasons for an injustice]. BaƱos JE Med Clin (Barc); 1997 Sep; 109(8):294-6. PubMed ID: 9379751 [No Abstract] [Full Text] [Related]
34. Heroin--the next step. Ley DC J Palliat Care; 1986 Apr; 1(2):46-7. PubMed ID: 2453637 [No Abstract] [Full Text] [Related]
35. Sources of variation in morphine analgesia in cancer patients with chronic pain. Kaiko RF; Wallenstein SL; Rogers AG; Houde RW NIDA Res Monogr; 1982 Apr; 41():294-300. PubMed ID: 6811922 [No Abstract] [Full Text] [Related]
36. Intraventricular diamorphine via an Ommaya shunt for intractable cancer pain. Reeve WG; Todd JG Br J Anaesth; 1990 Oct; 65(4):544-7. PubMed ID: 2248824 [TBL] [Abstract][Full Text] [Related]
37. [Pain control at home in cooperation with hospitals]. Sugimoto Y; Ito M; Hotta K; Toguchi M; Maeda K Gan To Kagaku Ryoho; 2003 Dec; 30(1 Suppl):132-4. PubMed ID: 15311784 [TBL] [Abstract][Full Text] [Related]